Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya™ for fibromyalgia management
Via News Direct
Exposures Product Safety
Tickers TNXP
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth
Via Benzinga
Exposures Product Safety
Tickers ABT
Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
Via Newsfile
Exposures Product Safety
Tickers CTXR
FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
Tickers CURLF
Waikiki Beach Services: A Legacy of Aloha and Leadership
Via Small Business Trendsetters
Topics Product Recall
Exposures Legal Product Safety
InvestorNewsBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Lomecel-B(TM) Granted Fast Track Designation for Treatment of Mild Alzheimer’s Disease
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Seasoned Veteran as Chief Financial Officer
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
LGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track Designation
Via InvestorPlace
Exposures Product Safety
Tickers GTLB HOVR LGVN TSM
Power Leaves Corp. and Abstrax Set to Transform U.S. Beverage & Cannabis Markets with Innovative Coca Leaf Products
Via NewMediaWire
Topics Cannabis Derivatives
Exposures Cannabis Derivatives Product Safety
What's Going On With Huamacyte Shares Tuesday?
Via Benzinga
Exposures Product Safety
Tickers HUMA
BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Approval for New Form of Buntanetap
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ANVS
Medicus Pharma CEO Dr. Raza Bokhari Announces Updated Phase 2 Clinical Protocol Submission to FDA
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers SILO
Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital first care and research to everyone
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers HSBC
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
Via AB Newswire
Exposures Product Safety
Tickers BSEM
Top Realtor in Petaluma, CA, Reflects on Journey from Recession Start in 2010 to Industry Success
Via AB Newswire
Topics Economy Product Recall
Exposures Economy Legal Product Safety
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BSEM
Trump Shooting Recalls Memories Of Reagan Assassination Attempt: Here's How Markets React To Political Violence
Via Benzinga
Topics Government Product Recall
Exposures Legal Political Product Safety
Tickers DIA DJT SPY
CCHR Commends Congressional Action to Prevent Continued Use of Electrical Shocking Device
Via Press Release Distribution Service
Exposures Product Safety
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
Via The Motley Fool
Exposures Product Safety
Tickers LLY
Bill Gates Recalls Barack Obama's Mission To Capture Osama bin Laden In Pakistan Using Fake Polio Vaccination Campaign: '...A Lot Of Damage Had Been Done'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers MSFT
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
Via Benzinga
Exposures Product Safety
Silk Recalls 2024: What to Know as Plant-Based Milk Recalled Over Listeria Concerns
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers FCEL JOBY KZIA WMT
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Prepares to Submit Briefing Book to FDA, Looks to Obtain Key Feedback Regarding NDA for CNM-Au8 in ALS
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Salmonella Saga: FDA Reportedly Uncovers Years of Contamination at PepsiCo Plant
Via Benzinga
Exposures Product Safety
Tickers CHWY IYK PEP XLP
First Choice Neurology Pioneering Neurologists Administer the New FDA-Approved Drug Kisunla
Via PRLog
Exposures Product Safety
Tickers LLY
From Chicago Streets to California Politics: A Riveting Memoir of Triumph Over Adversity
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Surprise Buying Opportunity on This Dividend Aristocrat
Via MarketBeat
Topics Economy Product Recall
Exposures Interest Rates Legal Product Safety
Tickers PEP
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
Via Benzinga
Exposures Product Safety
Tickers NVO
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.